Life Science REIT (LON:LABS) Shares Down 0.3% – Here’s Why

Life Science REIT plc (LON:LABS) traded down 0.3% on Wednesday . The stock traded as low as GBX 33.20 ($0.41) and last traded at GBX 33.60 ($0.42). 504,803 shares were traded during mid-day trading, a decline of 39% from the average session volume of 830,460 shares. The stock had previously closed at GBX 33.70 ($0.42).

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 57 ($0.71) price target on shares of Life Science REIT in a report on Thursday, October 3rd.

Life Science REIT Trading Down 0.3 %

The stock has a market cap of £117.60 million, a P/E ratio of -560.00 and a beta of 0.08. The stock’s 50-day moving average is GBX 36.91 and its 200-day moving average is GBX 36.62.

Life Science REIT Company Profile

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.